dpp-4 inhibitors and glp-1 agonists Specific actions of receptor DPP4 for the treatment of pancreatic β-cell impairments in type 2 diabetes It's the first in a
Description
Body composition and muscle preservation As GLP-1 RAs become more widely used for weight management, attention has turned to their effects on body composition
After treatment, serotonin reuptake transporter (SERT) increased, while tryptophan hydroxylase-1 (TPH-1) decreased in the colon, showing that exendin-4 may reduce pain by regulating SERT and TPH-1 levels

It does not only enhance treatment results but also helps in maintaining weight in the long term, promoting individualized care

Some have proposed miRNAs as biomarkers for predicting how well diabetic medications will work [161]

Tanaka N, Aoyama T, Kimura S, Gonzalez FJ

J Neurosci 37(48):1170111714
